Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients

European Journal of Surgical Oncology

Volumn 39, Issue 12, 2013, Pages 1435-1443

  Bakrin, N ^a,b   Bereder, J M ^c   Decullier, E ^a,d   Classe, J M ^e   Msika, S ^f   Lorimier, G ^g   Abboud, K ^h   Meeus, P ⁱ   Ferron, G ^j   Quenet, F ^k   Marchal, F ^l   Gouy, S ^m   Morice, P ^m   Pomel, C ⁿ   Pocard, M ^o   Guyon, F ^p   Porcheron, J ⁱ   Glehen, O ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e CENTRE RENÉ GAUDUCHEAU   (France)

^f HÔPITAL LOUIS MOURIER   (France)

^g CENTRE PAUL PAPIN   (France)

^h HÔPITAL NORD   (France)

ⁱ CENTRE LÉON BÉRARD   (France)

^j INSTITUT CLAUDIUS REGAUD   (France)

^k CENTRE VAL D AURELLE   (France)

^l CENTRE ALEXIS VAUTRIN   (France)

^m INSTITUT GUSTAVE ROUSSY   (France)

ⁿ CENTRE JEAN PERRIN   (France)

^o HÔPITAL LARIBOISIÈRE   (France)

^p Intitut Bergonie   (France)

more..

Author keywords

HIPEC; Hyperthermia; Intraperitoneal chemotherapy; Ovarian cancer; Peritoneal carcinomatosis

Indexed keywords

CISPLATIN; DOXORUBICIN; MITOMYCIN; OXALIPLATIN;

ABDOMINAL BLEEDING; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CHEMOSENSITIVITY; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CYTOREDUCTIVE SURGERY; DIGESTIVE SYSTEM FISTULA; DISEASE FREE SURVIVAL; FEMALE; FRANCE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; KIDNEY FAILURE; LEUKOPENIA; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MORBIDITY; MULTICENTER STUDY (TOPIC); OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENT CANCER; REOPERATION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL TIME;

HIPEC; HYPERTHERMIA; INTRAPERITONEAL CHEMOTHERAPY; OVARIAN CANCER; PERITONEAL CARCINOMATOSIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DIGESTIVE SYSTEM FISTULA; DISEASE-FREE SURVIVAL; FEMALE; FRANCE; HUMANS; HYPERTHERMIA, INDUCED; KAPLAN-MEIER ESTIMATE; LEUKOPENIA; MIDDLE AGED; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; POSTOPERATIVE HEMORRHAGE; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84888288716     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.09.030     Document Type: Article

References (30)

1. R.E. Bristow, R.S. Tomacruz, and D.K. Armstrong Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 2002 1248 1259
2. R.E. Bristow, I. Puri, and D.S. Chi Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis Gynecol Oncol 112 2009 265 274
3. O. Glehen, F. Mohamed, and F.N. Gilly Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia Lancet Oncol 5 2004 219 228
4. O. Glehen, F.N. Gilly, and F. Boutitie Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients Cancer 116 2010 5608 5618
5. T.C. Chua, B. Moran, and P.H. Sugarbaker Early and long-term outcome data on 2298 patients with pseudomyxoma peritonei of appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy J Clin Oncol 30 2012 2449 2456
6. T.D. Yan, M. Deraco, and D. Baratti Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience J Clin Oncol 27 2009 6237 6242
7. D. Elias, F. Gilly, and F. Boutitie Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study J Clin Oncol 28 2010 63 68
8. V.J. Verwaal, S. Bruin, and H. Boot 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer Ann Surg Oncol 15 2008 2426 2432
9. D.S. Alberts, P.Y. Liu, and E.V. Hannigan Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer N Engl J Med 335 1996 1950 1955
10. M. Markman, B.N. Bundy, and D.S. Alberts Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group J Clin Oncol 19 2001 1001 1007
11. D.K. Armstrong, B. Bundy, and L. Wenzel Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 2006 34 43
12. G. Crile Jr. The effects of heat and radiation on cancers implanted on the feet of mice Cancer Res 23 1963 372 380
13. K. Van der Speeten, O.A. Stuart, and P.H. Sugarbaker Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy Cancer J 15 2009 216 224
14. C.W. Helm The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer Oncologist 14 2009 683 694
15. R.M. Bukowski, R.F. Ozols, and M. Markman The management of recurrent ovarian cancer Semin Oncol 34 2007 S1 15
16. P. Jacquet, and P.H. Sugarbaker Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Cancer Treat Res 82 1996 359 374
17. Common terminology criteria for adverse events (CTCAE). Version 4.0 2009
18. I. Vergote, C.G. Trope, and F. Amant Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer N Engl J Med 363 2010 943 953
19. D.S. Chi, E.L. Eisenhauer, and J. Lang What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103 2006 559 564
20. S.M. Eisenkop, N.M. Spirtos, and R.L. Friedman Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study Gynecol Oncol 90 2003 390 396
21. A.R. Munkarah, and R.L. Coleman Critical evaluation of secondary cytoreduction in recurrent ovarian cancer Gynecol Oncol 95 2004 273 280
22. P. Harter, M. Hahmann, and H.J. Lueck Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis Ann Surg Oncol 16 2009 1324 1330
23. Helm CW, Richard SD, Pan J, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. Int J Gynecol Cancer 20:61-69.
24. E. Cotte, O. Glehen, and F. Mohamed Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients World J Surg 31 2007 1813 1820
25. C.W. Helm, R.E. Bristow, and S. Kusamura Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer J Surg Oncol 98 2008 283 290
26. C. Zanon, R. Clara, and I. Chiappino Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer World J Surg 28 2004 1040 1045
27. L. Gonzalez-Bayon, M.A. Steiner, and W. Vasquez Jimenez Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: upfront therapy, at first recurrence, or later? Eur J Surg Oncol 2013 10.1016/j.ejso.2013.06.022
28. E. Cotte, G. Passot, and F. Mohamed Management of peritoneal carcinomatosis from colorectal cancer: current state of practice Cancer J 15 2009 243 248
29. M. Muller, M. Cherel, and P.F. Dupre Cytotoxic effect of hyperthermia and chemotherapy with platinum salt on ovarian cancer cells: results of an in vitro study Eur Surg Res 46 2011 139 147
30. A.G. Portilla, K. Shigeki, and B. Dario The intraoperative staging systems in the management of peritoneal surface malignancy J Surg Oncol 98 2008 228 231